ADORA2A and amyotrophic lateral sclerosis: In this article, we review the possible mechanisms of chronic neurodegeneration via the adenosinergic system, the potential of uric acid as a biomarker and the acute symptomatic pharmacology (including phrenic motor facilitation) of A2A receptor antagonism to explore the potential of the A2A receptor (A2AR) as target for ALS therapy.